Ischaemic left ventricular dysfunction: a preventable precursor of heart failure? D. G. Waller SPECIAL ARTICLE Pages: 379 - 388
Current therapeutic uses and potential of β-adrenoceptor agonists and antagonists G. EmilienJ.-M. MaloteauxG. Emilion SPECIAL ARTICLE Pages: 389 - 404
Oral metamizol (1 g and 2 g) versus ibuprofen and placebo in the treatment of lower third molar surgery pain: randomised double-blind multi-centre study M. E. PlanasC. Gay-EscodaCooperative Study Group PHARMACODYNAMICS Pages: 405 - 409
The effect of Y-25510 injection on the serum levels of some cytokines in healthy adult volunteers J. AzumaM. OguraS. Asano PHARMACODYNAMICS Pages: 411 - 419
Adjunctive lamotrigine therapy in patients with refractory seizures: a lifetime cost–utility analysis A. MessoriS. TrippoliG. Zaccara PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 421 - 427
Pharmacokinetics of glibenclamide and its metabolites in diabetic patients with impaired renal function A. JönssonT. RydbergA. Melander PHARMACOKINETICS AND DISPOSITION Pages: 429 - 435
Pharmacokinetics of low doses of methotrexate in patients with psoriasis over the early period of treatment J. ChládekJ. MartínkováM. Nožičková PHARMACOKINETICS AND DISPOSITION Pages: 437 - 444
Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174 K.-M. KaukonenK. T. OlkkolaP. J. Neuvonen PHARMACOKINETICS AND DISPOSITION Pages: 445 - 449
An interaction study with cimetidine and the new angiotensin II antagonist valsartan E. K. SchmidtK.-H. AntoninA. Racine-Poon PHARMACOKINETICS AND DISPOSITION Pages: 451 - 458
Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration H. MöllmannM. WagnerH. Derendorf PHARMACOKINETICS AND DISPOSITION Pages: 459 - 467
Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin W. MückK. OchmannJ. Kuhlmann PHARMACOKINETICS AND DISPOSITION Pages: 469 - 473
Cimetidine does not alter atorvastatin pharmacokinetics or LDL-cholesterol reduction R. H. SternD. M. GibsonL. R. Whitfield PHARMACOKINETICS AND DISPOSITION Pages: 475 - 478
Effect of the serotonin4 receptor agonist cisapride on plasma aldosterone levels in cirrhotic patients with secondary hyperaldosteronism H. LefebvreF. HéronJ. M. Kuhn LETTER TO THE EDITORS Pages: 479 - 480